Zymeworks Inc
NASDAQ:ZYME

Watchlist Manager
Zymeworks Inc Logo
Zymeworks Inc
NASDAQ:ZYME
Watchlist
Price: 12.58 USD 2.69% Market Closed
Market Cap: 866.5m USD

Wall Street
Price Targets

ZYME Price Targets Summary
Zymeworks Inc

Wall Street analysts forecast ZYME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZYME is 20.85 USD with a low forecast of 12.12 USD and a high forecast of 31.5 USD.

Lowest
Price Target
12.12 USD
4% Downside
Average
Price Target
20.85 USD
66% Upside
Highest
Price Target
31.5 USD
150% Upside
Zymeworks Inc Competitors:
Price Targets
300122
Chongqing Zhifei Biological Products Co Ltd
33% Upside
LVTX
LAVA Therapeutics NV
69% Upside
MAB
Mabion SA
20% Downside
068270
Celltrion Inc
31% Upside
214450
PharmaResearch Co Ltd
4% Upside
MOLN
Molecular Partners AG
206% Upside
4597
Solasia Pharma KK
41% Upside
CUV
Clinuvel Pharmaceuticals Ltd
123% Upside

Revenue
Forecast

Revenue Estimate
Zymeworks Inc

For the last 8 years the compound annual growth rate for Zymeworks Inc's revenue is 29%. The projected CAGR for the next 4 years is 19%.

29%
Past Growth
19%
Estimated Growth
Estimates Accuracy
6%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Zymeworks Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Net Income
Forecast

Net Income Estimate
Zymeworks Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZYME's stock price target?
Price Target
20.85 USD

According to Wall Street analysts, the average 1-year price target for ZYME is 20.85 USD with a low forecast of 12.12 USD and a high forecast of 31.5 USD.

What is Zymeworks Inc's Revenue forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Zymeworks Inc's revenue is 29%. The projected CAGR for the next 4 years is 19%.

Back to Top